Evidence map›Paper›PMID 39940711›Full record

ArticleInternational journal of molecular sciences2025

Probiotic Spores of

Rowena Corona, Valeria Bontà, Loredana Baccigalupi, Ezio Ricca

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rowena CoronaGruppo Savio, 00071 Pomezia, Italy.
Valeria BontàGruppo Savio, 00071 Pomezia, Italy.
Loredana BaccigalupiDepartment of Molecular Medicine and Medical Biotechnology, Federico II University of Naples, 80126 Naples, Italy.
Ezio RiccaDepartment of Biology, Federico II University of Naples, 80126 Naples, Italy.ORCID 0000-0002-7355-0332

Funding

Gruppo SAVIO (Italy) Progetto spore 2024
6 · The paper itself

Abstract

Probiotics have health-beneficial properties mainly due to either a direct action on the host or the modulation of the host microbiota. Health-beneficial properties have also been associated with a variety of plant-derived molecules, widely used as dietary supplements. This study explores the possibility of combining the actions of probiotics and of plant-derived molecules by developing beneficial, probiotic-carrying, heterologous molecules. To this extent, spores of SF174, a well-characterized probiotic strain of

Indexed as

Bacillus clausiiBromelainsProbioticsSpores, BacterialAntioxidantsEndopeptidasesAntioxidantsBromelainsEndopeptidasesantioxidantsBacillus clausiibeneficial bacteriafunctional probioticssurface display

Identifiers

PMID39940711
PMCPMC11817855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.